Completed
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
NCT03508700
- Conditions
- Mental Disorders, PTSD, Stress Disorders, Post-Traumatic, +2 more
- Locations
-
- Little Rock Little Rock, Arkansas, United States
- Beverly Hills Beverly Hills, California, United States
- Oceanside Oceanside, California, United States
- Orange Orange, California, United States